SCHEMBL21471731

SCHEMBL21471731

C=CCN1CCc2cc(C(=O)c3nc(C#N)c[nH]3)sc2-c2ccc(F)cc21

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.33
AR P10275 1/20 0.32
CHRM2 P08172 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21471717 0.80 MAPK14 (0.41) NOTUMCHRM2CHRM3
SCHEMBL21474620 0.80 MAPK14 (0.41) NOTUMCHRM2CHRM3
SCHEMBL20599068 0.79 NOTUM (0.46) NOTUMCHRM2CHRM3
SCHEMBL21471714 0.79 CHRM2 (0.38) NOTUMCHRM2CHRM3
SCHEMBL21471603 0.79 NOTUM (0.38) NOTUM
SCHEMBL21471683 0.78 CHRM2 (0.36) NOTUMARCHRM2CHRM3
SCHEMBL21471676 0.77 CHRM2 (0.32) NOTUMARCHRM2CHRM3
SCHEMBL21471614 0.76 KDM4E (0.36) NOTUMARCHRM2CHRM3
SCHEMBL21471675 0.76 ALDH1A1 (0.47) NOTUMARCHRM2CHRM3
SCHEMBL20622402 0.75 HPGD (0.42) CHRM2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019199908-A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-10-17 WO disclosed